Five Prime Therapeutics Inc (FPRX)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

111 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO, CA 94080

Five Prime Therapeutics, Inc. provides clinical stage biotech services. The company discovers and develops a complete range of innovative protein and antibody therapeutics, as well as offers drugs for oncology and immunology diseases. FivePrime conducts business throughout the United States and Canada.

Data as of 2020-11-22
Market Cap822.139 Million Shares Outstanding46.318 Million Avg 30-day Volume4.405 Million
P/E Ratio-6.6 Dividend Yield EPS-2.68
Price/Sales48.09 Price cash flow ratio4.8 Price free cash flow ratio-10.1
Book Value2.06 Price to Tangible Book8.63 Alpha-0.03
Short Interest Ratio % Short Interest to Float R-squared0.172024
BETA1.87672 52-week High/Low24.7 / 1.75 Stddev0.190681
View SEC Filings from FPRX instead.
Q3 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 0 0 0 (0.0%) 0 (0.0%)
Funds Holding: 92 97 -5.15% 37 (2.43%) 39 (2.53%) -5.13%
13F shares: 26.213 Million 26.901 Million -2.56% 18.888 Million 19.304 Million -2.15%
% Ownership 71.5643 73.4452 -2.56% 51.5672 52.702 -2.15%
New Positions: 8 22 -63.64% 2 6 -66.67%
Increased Positions 24 30 -20.0% 13 17 -23.53%
Closed Positions 12 10 20.0% 4 2 100.0%
Reduced Positions 32 32 0.0% 12 12 0.0%
Total Calls 46.239 Thousand 83.98 Thousand -44.94% 16.5 Thousand
Total Puts 33 Thousand 35 Thousand -5.71%
PUT/CALL Ratio 0.71 0.42 69.05% 0.0
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding FPRX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding FPRX BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

791.8 Thousand total shares from 9 transactions

Open Market Sells (S)

7.5 Million total shares from 5 transactions

Exercise Derivative Conversion (M)

145 Thousand total shares from 5 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

SARENA FRANCIS WILLARD CHIEF STRATEGY OFFICER

  • Officer
116,010 2020-11-11 3

RINGO WILLIAM R

  • Director
10,000 2020-11-11 8

COLLINS HELEN LOUISE EVP AND CHIEF MEDICAL OFFICER

  • Officer
75,117 2020-11-11 5

SMITH DAVID V EXECUTIVE VICE PRESIDENT & CFO

  • Officer
74,481 2020-11-11 3

BVF PARTNERS L P/IL

BIOTECHNOLOGY VALUE FUND L P

BVF I GP LLC

BIOTECHNOLOGY VALUE FUND II LP

BVF II GP LLC

BIOTECHNOLOGY VALUE TRADING FUND OS LP

BVF PARTNERS OS LTD.

BVF GP HOLDINGS LLC

BVF INC/IL

LAMPERT MARK N

  • SEE EXPLANATON OF RESPONSESSEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSES
1,237,471 2020-11-11 5

WHITE DAVID SEE REMARKS

  • Officer
36,039 2020-09-30 3

BERGER FRANKLIN M

  • Director
0 2020-05-14 2

JENSEN PEDER

  • Director
0 2020-05-14 1

DHINGRA KAPIL

  • Director
0 2020-05-14 1

NICHOLSON GARRY A

  • Director
0 2020-05-14 1

SCHAFER CAROL

  • Director
0 2020-05-14 1

LYONS-WILLIAMS LORI

  • Director
0 2020-05-14 1

BVF GP HOLDINGS LLC

BVF I GP LLC

BVF II GP LLC

  • 10% Owner
  • SEE EXPLANATION OF RESPONSES
7,008,781 2020-05-14 1

CIVIK THOMAS PRESIDENT AND CEO

  • Officer
  • Director
75,000 2020-04-13 2

BVF PARTNERS L P/IL

BIOTECHNOLOGY VALUE FUND L P

BIOTECHNOLOGY VALUE FUND II LP

BIOTECHNOLOGY VALUE TRADING FUND OS LP

BVF PARTNERS OS LTD.

BVF INC/IL

LAMPERT MARK N

  • 10% Owner
  • SEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSES
536,608 2019-12-20 2

KNICKERBOCKER ARON MARC PRESIDENT & CEO

  • Officer
  • Director
242,356 2019-09-01 0

WILLIAMS LEWIS T

  • Director
455,336 2019-09-01 0

IRVING BRYAN EVP, CHIEF SCIENTIFIC OFFICER

  • Officer
30,533 2019-05-15 0

WILLIAMS LEWIS T EXECUTIVE CHAIRMAN

WILLIAMS LEWIS T EXECUTIVE CHAIRMAN

  • Officer
  • Director
465,430 2018-11-05 0

MCDADE MARK

  • Director
0 2018-05-10 0

GUJRATHI SHEILA

  • Director
0 2018-05-10 0

RUBINSTEIN LINDA M INTERIM CFO

  • Officer
0 2018-04-13 0

BELSKY MARC SENIOR VICE PRESIDENT AND CFO

  • Officer
60,472 2018-02-26 0

BAKER KEVIN PAUL SVP, DEVELOPMENT SCIENCES

  • Officer
78,184 2018-02-26 0

COHEN FRED E

  • Director
0 2017-05-10 0

SIKORSKI ROBERT STEVEN SVP AND CHIEF MEDICAL OFFICER

  • Officer
104,158 2017-03-01 0

BORGES LUIS SVP, RESEARCH

  • Officer
64,888 2017-03-01 0

DOUGLAS R LEE

  • Director
16,862 2016-10-12 0

HAMBLETON JULIE EVP & CHIEF MEDICAL OFFICER

  • Officer
86,575 2015-11-11 0

ADAGE CAPITAL PARTNERS GP LLC

ADAGE CAPITAL PARTNERS, L.P.

ADAGE CAPITAL ADVISORS, L.L.C.

ATCHINSON ROBERT

GROSS PHILLIP

  • 10% Owner
No longer subject to file 2015-10-15 0

ATWOOD BRIAN G

  • Director
0 2015-06-12 0

WONG BRIAN RUSSELL SVP, RESEARCH

  • Officer
22,738 2015-06-12 0

KAVANAUGH WILLIAM MICHAEL SVP & CHIEF SCIENTIFIC OFFICER

  • Officer
0 2014-08-22 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

BVF PARTNERS L P/IL SEE EXPLANATON OF RESPONSES

BIOTECHNOLOGY VALUE FUND L P SEE EXPLANATION OF RESPONSES

BVF I GP LLC SEE EXPLANATION OF RESPONSES

BIOTECHNOLOGY VALUE FUND II LP SEE EXPLANATION OF RESPONSES

BVF II GP LLC SEE EXPLANATION OF RESPONSES

BIOTECHNOLOGY VALUE TRADING FUND OS LP SEE EXPLANATION OF RESPONSES

BVF PARTNERS OS LTD. SEE EXPLANATION OF RESPONSES

BVF GP HOLDINGS LLC SEE EXPLANATION OF RESPONSES

BVF INC/IL SEE EXPLANATION OF RESPONSES

LAMPERT MARK N SEE EXPLANATION OF RESPONSES

2020-11-13 17:29:58 -0500 2020-11-11 S 2,949,477 $20.19 d 485,513 direct -3.0245 0.0 1 -3.0245 2

COLLINS HELEN LOUISE - Officer EVP AND CHIEF MEDICAL OFFICER

2020-11-13 12:25:37 -0500 2020-11-11 F 11,039 $18.00 d 75,117 direct -2.709 -17.0948 0.0 1 -17.0948 6

SARENA FRANCIS WILLARD - Officer CHIEF STRATEGY OFFICER

2020-11-13 12:38:04 -0500 2020-11-11 F 11,001 $18.00 d 116,010 direct -2.709 -17.0948 0.0 1 -17.0948 6

SMITH DAVID V - Officer EXECUTIVE VICE PRESIDENT & CFO

2020-11-13 12:29:32 -0500 2020-11-11 F 10,908 $18.00 d 74,481 direct -2.709 -17.0948 0.0 1 -17.0948 6

RINGO WILLIAM R - Director

2020-11-13 12:17:24 -0500 2020-11-11 M 52,959 d 0 direct yes

RINGO WILLIAM R - Director

2020-11-13 12:17:24 -0500 2020-11-11 S 52,959 $22.50 d 10,000 direct yes -2.709 -17.0948 0.0 1 -17.0948 6

BVF PARTNERS L P/IL SEE EXPLANATON OF RESPONSES

BIOTECHNOLOGY VALUE FUND L P SEE EXPLANATION OF RESPONSES

BVF I GP LLC SEE EXPLANATION OF RESPONSES

BIOTECHNOLOGY VALUE FUND II LP SEE EXPLANATION OF RESPONSES

BVF II GP LLC SEE EXPLANATION OF RESPONSES

BIOTECHNOLOGY VALUE TRADING FUND OS LP SEE EXPLANATION OF RESPONSES

BVF PARTNERS OS LTD. SEE EXPLANATION OF RESPONSES

BVF GP HOLDINGS LLC SEE EXPLANATION OF RESPONSES

BVF INC/IL SEE EXPLANATION OF RESPONSES

LAMPERT MARK N SEE EXPLANATION OF RESPONSES

2020-11-13 17:29:58 -0500 2020-11-11 S 3,941,214 $20.19 d 670,695 direct -3.0245 0.0 1 -3.0245 2

COLLINS HELEN LOUISE - Officer EVP AND CHIEF MEDICAL OFFICER

2020-11-13 12:25:37 -0500 2020-11-11 M 22,000 a 86,156 direct -2.709 -17.0948 0.0 1 -17.0948 6

SARENA FRANCIS WILLARD - Officer CHIEF STRATEGY OFFICER

2020-11-13 12:38:04 -0500 2020-11-11 M 22,000 a 127,011 direct -2.709 -17.0948 0.0 1 -17.0948 6

SMITH DAVID V - Officer EXECUTIVE VICE PRESIDENT & CFO

2020-11-13 12:29:32 -0500 2020-11-11 M 22,000 a 85,389 direct -2.709 -17.0948 0.0 1 -17.0948 6

RINGO WILLIAM R - Director

2020-11-13 12:17:24 -0500 2020-11-11 S 26,000 $22.50 d 10,000 direct yes -2.709 -17.0948 0.0 1 -17.0948 6

RINGO WILLIAM R - Director

2020-11-13 12:17:24 -0500 2020-11-11 M 52,959 $2.22 a 62,959 direct -2.709 -17.0948 0.0 1 -17.0948 6

BVF PARTNERS L P/IL SEE EXPLANATON OF RESPONSES

BIOTECHNOLOGY VALUE FUND L P SEE EXPLANATION OF RESPONSES

BVF I GP LLC SEE EXPLANATION OF RESPONSES

BIOTECHNOLOGY VALUE FUND II LP SEE EXPLANATION OF RESPONSES

BVF II GP LLC SEE EXPLANATION OF RESPONSES

BIOTECHNOLOGY VALUE TRADING FUND OS LP SEE EXPLANATION OF RESPONSES

BVF PARTNERS OS LTD. SEE EXPLANATION OF RESPONSES

BVF GP HOLDINGS LLC SEE EXPLANATION OF RESPONSES

BVF INC/IL SEE EXPLANATION OF RESPONSES

LAMPERT MARK N SEE EXPLANATION OF RESPONSES

2020-11-13 17:29:58 -0500 2020-11-11 S 502,649 $20.19 d 81,263 direct -3.0245 0.0 1 -3.0245 2

COLLINS HELEN LOUISE - Officer EVP AND CHIEF MEDICAL OFFICER

2020-11-13 12:25:37 -0500 2020-11-11 M 22,000 d 22,000 direct

SARENA FRANCIS WILLARD - Officer CHIEF STRATEGY OFFICER

2020-11-13 12:38:04 -0500 2020-11-11 M 22,000 d 22,000 direct

SMITH DAVID V - Officer EXECUTIVE VICE PRESIDENT & CFO

2020-11-13 12:29:32 -0500 2020-11-11 M 22,000 d 22,000 direct

RINGO WILLIAM R - Director

2020-11-13 12:17:24 -0500 2020-11-11 M 26,000 d 52,408 direct yes

RINGO WILLIAM R - Director

2020-11-13 12:17:24 -0500 2020-11-11 M 26,000 $2.80 a 36,000 direct -2.709 -17.0948 0.0 1 -17.0948 6

BVF PARTNERS L P/IL - > 10% Owner

BIOTECHNOLOGY VALUE FUND L P - > 10% Owner

BVF I GP LLC - > 10% Owner

BIOTECHNOLOGY VALUE FUND II LP SEE EXPLANATION OF RESPONSES

BVF II GP LLC SEE EXPLANATION OF RESPONSES

BIOTECHNOLOGY VALUE TRADING FUND OS LP SEE EXPLANATION OF RESPONSES

BVF PARTNERS OS LTD. SEE EXPLANATION OF RESPONSES

BVF GP HOLDINGS LLC - > 10% Owner

BVF INC/IL - > 10% Owner

LAMPERT MARK N - > 10% Owner

2020-11-06 18:30:18 -0500 2020-11-06 P 17,230 $4.98 a 4,611,909 direct -2.7322 279.4171 308.561 4 -2.7322 2

BVF PARTNERS L P/IL - > 10% Owner

BIOTECHNOLOGY VALUE FUND L P - > 10% Owner

BVF I GP LLC - > 10% Owner

BIOTECHNOLOGY VALUE FUND II LP SEE EXPLANATION OF RESPONSES

BVF II GP LLC SEE EXPLANATION OF RESPONSES

BIOTECHNOLOGY VALUE TRADING FUND OS LP SEE EXPLANATION OF RESPONSES

BVF PARTNERS OS LTD. SEE EXPLANATION OF RESPONSES

BVF GP HOLDINGS LLC - > 10% Owner

BVF INC/IL - > 10% Owner

LAMPERT MARK N - > 10% Owner

2020-11-06 18:30:18 -0500 2020-11-06 P 10,436 $4.98 a 3,434,990 direct -2.7322 279.4171 308.561 4 -2.7322 2

BVF PARTNERS L P/IL - > 10% Owner

BIOTECHNOLOGY VALUE FUND L P - > 10% Owner

BVF I GP LLC - > 10% Owner

BIOTECHNOLOGY VALUE FUND II LP SEE EXPLANATION OF RESPONSES

BVF II GP LLC SEE EXPLANATION OF RESPONSES

BIOTECHNOLOGY VALUE TRADING FUND OS LP SEE EXPLANATION OF RESPONSES

BVF PARTNERS OS LTD. SEE EXPLANATION OF RESPONSES

BVF GP HOLDINGS LLC - > 10% Owner

BVF INC/IL - > 10% Owner

LAMPERT MARK N - > 10% Owner

2020-11-06 18:30:18 -0500 2020-11-06 P 2,334 $4.98 a 583,912 direct -2.7322 279.4171 308.561 4 -2.7322 2

BVF PARTNERS L P/IL - > 10% Owner

BIOTECHNOLOGY VALUE FUND L P - > 10% Owner

BVF I GP LLC - > 10% Owner

BIOTECHNOLOGY VALUE FUND II LP SEE EXPLANATION OF RESPONSES

BVF II GP LLC SEE EXPLANATION OF RESPONSES

BIOTECHNOLOGY VALUE TRADING FUND OS LP SEE EXPLANATION OF RESPONSES

BVF PARTNERS OS LTD. SEE EXPLANATION OF RESPONSES

BVF GP HOLDINGS LLC - > 10% Owner

BVF INC/IL - > 10% Owner

LAMPERT MARK N - > 10% Owner

2020-11-06 18:30:18 -0500 2020-11-04 P 15,355 $4.88 a 581,578 direct -2.7322 279.4171 308.561 4 -2.7322 2

BVF PARTNERS L P/IL - > 10% Owner

BIOTECHNOLOGY VALUE FUND L P - > 10% Owner

BVF I GP LLC - > 10% Owner

BIOTECHNOLOGY VALUE FUND II LP SEE EXPLANATION OF RESPONSES

BVF II GP LLC SEE EXPLANATION OF RESPONSES

BIOTECHNOLOGY VALUE TRADING FUND OS LP SEE EXPLANATION OF RESPONSES

BVF PARTNERS OS LTD. SEE EXPLANATION OF RESPONSES

BVF GP HOLDINGS LLC - > 10% Owner

BVF INC/IL - > 10% Owner

LAMPERT MARK N - > 10% Owner

2020-11-06 18:30:18 -0500 2020-11-04 P 257,804 $4.88 a 4,594,679 direct -2.7322 279.4171 308.561 4 -2.7322 2

BVF PARTNERS L P/IL - > 10% Owner

BIOTECHNOLOGY VALUE FUND L P - > 10% Owner

BVF I GP LLC - > 10% Owner

BIOTECHNOLOGY VALUE FUND II LP SEE EXPLANATION OF RESPONSES

BVF II GP LLC SEE EXPLANATION OF RESPONSES

BIOTECHNOLOGY VALUE TRADING FUND OS LP SEE EXPLANATION OF RESPONSES

BVF PARTNERS OS LTD. SEE EXPLANATION OF RESPONSES

BVF GP HOLDINGS LLC - > 10% Owner

BVF INC/IL - > 10% Owner

LAMPERT MARK N - > 10% Owner

2020-11-06 18:30:18 -0500 2020-11-04 P 143,403 $4.88 a 3,424,554 direct -2.7322 279.4171 308.561 4 -2.7322 2

BVF PARTNERS L P/IL - > 10% Owner

BIOTECHNOLOGY VALUE FUND L P - > 10% Owner

BVF I GP LLC - > 10% Owner

BIOTECHNOLOGY VALUE FUND II LP SEE EXPLANATION OF RESPONSES

BVF II GP LLC SEE EXPLANATION OF RESPONSES

BIOTECHNOLOGY VALUE TRADING FUND OS LP SEE EXPLANATION OF RESPONSES

BVF PARTNERS OS LTD. SEE EXPLANATION OF RESPONSES

BVF GP HOLDINGS LLC - > 10% Owner

BVF INC/IL - > 10% Owner

LAMPERT MARK N - > 10% Owner

2020-10-08 17:27:43 -0400 2020-10-06 P 162,352 $5.04 a 3,281,151 direct 13.197 10.7807 229.9257 316.9145 25 -15.2416 16

BVF PARTNERS L P/IL - > 10% Owner

BIOTECHNOLOGY VALUE FUND L P - > 10% Owner

BVF I GP LLC - > 10% Owner

BIOTECHNOLOGY VALUE FUND II LP SEE EXPLANATION OF RESPONSES

BVF II GP LLC SEE EXPLANATION OF RESPONSES

BIOTECHNOLOGY VALUE TRADING FUND OS LP SEE EXPLANATION OF RESPONSES

BVF PARTNERS OS LTD. SEE EXPLANATION OF RESPONSES

BVF GP HOLDINGS LLC - > 10% Owner

BVF INC/IL - > 10% Owner

LAMPERT MARK N - > 10% Owner

2020-10-08 17:27:43 -0400 2020-10-06 P 157,782 $5.04 a 4,336,875 direct 13.197 10.7807 229.9257 316.9145 25 -15.2416 16

BVF PARTNERS L P/IL - > 10% Owner

BIOTECHNOLOGY VALUE FUND L P - > 10% Owner

BVF I GP LLC - > 10% Owner

BIOTECHNOLOGY VALUE FUND II LP SEE EXPLANATION OF RESPONSES

BVF II GP LLC SEE EXPLANATION OF RESPONSES

BIOTECHNOLOGY VALUE TRADING FUND OS LP SEE EXPLANATION OF RESPONSES

BVF PARTNERS OS LTD. SEE EXPLANATION OF RESPONSES

BVF GP HOLDINGS LLC - > 10% Owner

BVF INC/IL - > 10% Owner

LAMPERT MARK N - > 10% Owner

2020-10-08 17:27:43 -0400 2020-10-06 P 25,107 $5.04 a 566,223 direct 13.197 10.7807 229.9257 316.9145 25 -15.2416 16

WHITE DAVID - Officer SEE REMARKS

2020-10-02 13:51:16 -0400 2020-09-30 F 6,916 $4.70 d 36,039 direct 0.0 10.6996 340.535 361.5226 30 -6.1728 21

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

Elevate your investments